Isoleucy - CAS号查询

Angiotensin II,5-L-isoleucine-8-L-alanine- (8CI,9CI);
Alanine,N-[1-[N-[N-[N-[N-(N2-a-aspartylarginyl)valyl]tyrosyl]Isoleucyl]histidyl]prolyl]- (6CI);
5-Isoleucine-8-alanineangiotensin;
5-Isoleucine-8-alanine-angiotensin II;
5-L-Isoleucine-8-L-alanineangiotensin II;
8-Ala-Ang II;
[8-Alanine]-5-isoleucine-angiotensin II

C44H67N13O12

详情

供应商

4474-91-3

Angiotensin II,5-L-isoleucine-;
Alanine,N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-Isoleucyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI);
10: PN: WO0212471 SEQID: 17 unclaimed sequence;
113: PN:WO2008104000 TABLE: 4 unclaimed sequence;
11: PN: US20030119021 SEQID: 10unclaimed sequence;
1272: PN: US20050069911 SEQID: 1272 unclaimed sequence;
12:PN: US20090088553 SEQID: 86 unclaimed protein;
12: PN: WO0239997 SEQID: 17unclaimed sequence;
134: PN: WO02098448 SEQID: 144 unclaimed sequence;
134: PN:WO02098906 SEQID: 144 unclaimed sequence;
14: PN: WO2004007538 SEQID: 13claimed sequence;
154: PN: WO2009126292 TABLE: 4 unclaimed sequence;
17: PN:US6610497 SEQID: 17 unclaimed sequence;
17: PN: US6884771 SEQID: 17 unclaimedsequence;
17: PN: US6989363 SEQID: 17 unclaimed sequence;
17: PN: WO2006032674SEQID: 15 claimed sequence;
1: PN: CN101015689 SEQID: 1 claimed sequence;
1:PN: CN1706502 PAGE: 2 claimed sequence;
1: PN: US6022696 SEQID: 2 unclaimedsequence;
1: PN: WO0002905 SEQID: 1 claimed protein;

Antrimycin A (9CI);
CirratiomycinB;
L-Serine,2-(hydroxymethyl)seryl-L-alanyl-L-erythro-2,3-diaminobutanoyl-L-2,3,4,5-tetrahydro-3-pyridazinecarbonyl-L-alanyl-(E)-2,3-didehydroIsoleucyl-

Axinastatin 3 (9CI);
Axinastatin1, 4-L-isoleucine-5-L-leucine-;
1H-Dipyrrolo[1,2-a:1',2'-j][1,4,7,10,13,16,19]heptaazacycloheneicosine, cyclicpeptide deriv.;
Cyclo(L-asparaginyl-L-prolyl-L-phenylalanyl-L-Isoleucyl-L-leucyl-L-prolyl-L-valyl)

Angiotensin IIIinhibitor (human) (9CI);
AngiotensinII, 1-de-L-aspartic acid-5-L-isoleucine-8-L-isoleucine-;
16: PN: WO0069900SEQID: 665 unclaimed sequence;
462: PN: WO0069900 SEQID: 648 unclaimedsequence;
538: PN: US20090175821 SEQID: 648 claimed protein;
L-Isoleucine,L-arginyl-L-valyl-L-tyrosyl-L-Isoleucyl-L-histidyl-L-prolyl-;
L-Isoleucine,N-[1-[N-[N-[N-(N-L-arginyl-L-valyl)-L-tyrosyl]-L-Isoleucyl]-L-histidyl]-L-prolyl]-

Angiotensin I (Triakisscyllium) (9CI);
AngiotensinI, 1-L-asparagine-3-L-proline-5-L-isoleucine-9-L-glutamine-;
L-Leucine,L-asparaginyl-L-arginyl-L-prolyl-L-tyrosyl-L-Isoleucyl-L-histidyl-L-prolyl-L-phenylalanyl-L-glutaminyl-

Arthrofactin (9CI);
L-Asparticacid, N-[N-[N-[N-[N-[N-[N-[N-[N-[N-[N-(3-hydroxy-1-oxodecyl)-D-leucyl]-D-a-aspartyl]-D-threonyl]-D-leucyl]-D-leucyl]-D-seryl]-L-leucyl]-D-seryl]-L-Isoleucyl]-L-Isoleucyl]-,l1-lactone;
1-Oxa-4,7,10,13,16,19,22,25,28,31,34-undecaazacycloheptatriacontane, cyclicpeptide deriv.;
Cyclo(L-a-aspartyl-3-hydroxydecanoyl-D-leucyl-D-a-aspartyl-D-threonyl-D-leucyl-D-leucyl-D-seryl-L-leucyl-D-seryl-L-Isoleucyl-L-Isoleucyl)

Butanoic acid,N2-(2,5-dihydroxybenzoyl)-L-arginyl-L-prolyl-L-Isoleucyl-2-amino-, (2S)- (9CI);
Butanoicacid, N2-(2,5-dihydroxybenzoyl)-L-arginyl-L-prolyl-L-Isoleucyl-L-2-amino-;
Nazumamide A

Bradykinin potentiatorB (9CI);
Proline,1-[1-[N-[N2-[1-[N2-[1-[1-[N-[N-(5-oxo-L-prolyl)glycyl]-L-leucyl]-L-prolyl]-L-prolyl]-L-arginyl]-L-prolyl]-L-lysyl]-L-Isoleucyl]-L-prolyl]-,L- (8CI);
3: PN: WO2009039969 PAGE: 99 claimed protein;
Bradykinin potentiatingpeptide B;
Bradykinin-potentiating peptide B (Agkistrodon halys blomhoffiivenom);
L-Proline, 1-[1-[N-[N2-[1-[N2-[1-[1-[N-[N-(5-oxo-L-prolyl)glycyl]-L-leucyl]-L-prolyl]-L-prolyl]-L-arginyl]-L-prolyl]-L-lysyl]-L-Isoleucyl]-L-prolyl]-;
PGlu-Gly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro;
Pyroglu-Gly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro;
Pyroglutamylglycyl-L-leucyl-L-prolyl-L-prolyl-L-arginyl-L-prolyl-L-lysyl-L-Isoleucyl-L-prolyl-L-proline;
PyroglutamylglycylleucylprolylprolylarginylprolyllysylIsoleucylprolylproline

Bradykinin,N2-(L-Isoleucyl-L-seryl)-;
Bradykinin,N2-(N-L-Isoleucyl-L-seryl)-;
Isoleucine-serine-bradykinin;
Isoleucyl-serine-bradykinin;
T-kinin

Cyclo(L-Isoleucyl-L-prolyl-L-leucyl-O-methyl-D-tyrosyl)(9CI);
Cyclic(L-Isoleucyl-L-prolyl-L-leucyl-O-methyl-D-tyrosyl);
Pyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine, cyclic peptide deriv.;
Cyclic(L-leucyl-L-prolyl-L-leucyl-O-methyl-D-tyrosyl);
Cyclo(L-leucyl-L-prolyl-L-leucyl-O-methyl-D-tyrosyl)

Cyclo[L-alanyl-D-alloIsoleucyl-(3S,4S)-3-hydroxy-4-methyloctanoyl-L-phenylalanyl];
BeauveriolideIII;
FO 6979

Cyclo(a-amino-h-oxooxiraneoctanoyl-D-phenylalanyl-L-Isoleucyl-L-prolyl)(9CI);
Cyclo(8-oxiranyl-8-oxo-2-aminooctanoyl-D-phenylalanyl-L-Isoleucyl-L-prolyl);
PF 1070B

Cyclo(L-Isoleucyl-L-prolyl-L-prolyl-L-leucyl)(9CI);
1H,5H-Dipyrrolo[1,2-a:1',2'-d][1,4,7,10]tetraazacyclododecine,cyclic peptide deriv.;
Fenestin A

Cyclo(3-hydroxydecanoyl-D-leucyl-L-seryl-L-threonyl-D-leucyl-L-Isoleucyl)(9CI);
L-Isoleucine,N-(3-hydroxy-1-oxodecyl)-D-leucyl-L-seryl-L-threonyl-D-leucyl-, (5®
1)-lactone;
Kailuin A

Cyclo(alanyl-2-hydroxy-3-methylbutanoylIsoleucyl-2-hydroxy-3-methylbutanoylthreonyl)(9CI);
Cyclo(alanyl-3-methyl-2-hydroxybutanoylIsoleucyl-3-methyl-2-hydroxybutanoylthreonyl);
1,7-Dioxa-4,10,13-triazacyclopentadecane, cyclic peptide deriv.;
Roseotoxin S

Cyclo(alanylleucylIsoleucyl-2-aminobenzoyl-2-piperidinecarbonyl-N-methylleucyl);
PF 1171A

C35H54N6O6

详情

供应商

化工产品